Detecting Drug Resistant Tumor Cells Quickly
Author Information
Author(s): A. deFazio, M.H.N. Tattersall
Primary Institution: Ludwig Institute for Cancer Research (Sydney Branch)
Hypothesis
The mutation rate of a tumor can indicate its potential to develop drug resistance.
Conclusion
The study presents a rapid and sensitive assay for identifying drug-resistant tumor cells using a monoclonal antibody.
Supporting Evidence
- Previous studies have shown that drug resistance in tumors often arises from spontaneous mutations.
- The new assay can identify drug-resistant cells without needing high cloning efficiency.
- Cells that continue to cycle after drug exposure can be assumed to be resistant.
Takeaway
Scientists found a quick way to see if cancer cells can resist drugs by using a special marker that shows which cells are still alive after treatment.
Methodology
The study used a monoclonal antibody to detect bromodeoxyuridine in DNA, indicating drug resistance in cells exposed to a cytotoxic drug.
Potential Biases
The method may bias the estimation of mutation rates in favor of more malignant cells due to low cloning efficiency.
Limitations
The method cannot prove that identified cells are mutants since they cannot be clonally expanded.
Want to read the original?
Access the complete publication on the publisher's website